Derek Cruickshank

4.4k total citations
37 papers, 888 citations indexed

About

Derek Cruickshank is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Derek Cruickshank has authored 37 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Reproductive Medicine, 18 papers in Obstetrics and Gynecology and 10 papers in Surgery. Recurrent topics in Derek Cruickshank's work include Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Intraperitoneal and Appendiceal Malignancies (8 papers). Derek Cruickshank is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Intraperitoneal and Appendiceal Malignancies (8 papers). Derek Cruickshank collaborates with scholars based in United Kingdom, Belgium and Australia. Derek Cruickshank's co-authors include Fiona Kew, James Paul, Anthony Roberts, Peter A. van Dam, Amin Makar, Wiebren Tjalma, Arnold Klopper, Ian MacGillivray, Doris M. Campbell and N. A. Booth and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

Derek Cruickshank

36 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek Cruickshank United Kingdom 16 498 443 229 205 158 37 888
Ramey D. Littell United States 19 431 0.9× 390 0.9× 160 0.7× 129 0.6× 149 0.9× 45 941
Elisabeth Diver United States 16 338 0.7× 371 0.8× 271 1.2× 181 0.9× 124 0.8× 57 775
Mario Beiner Israel 23 713 1.4× 638 1.4× 216 0.9× 271 1.3× 215 1.4× 46 1.3k
Emanuela Rabaiotti Italy 17 406 0.8× 237 0.5× 204 0.9× 289 1.4× 290 1.8× 63 898
Jason Dodge Canada 14 646 1.3× 495 1.1× 173 0.8× 292 1.4× 98 0.6× 27 930
Taner Turan Türkiye 19 654 1.3× 693 1.6× 141 0.6× 331 1.6× 170 1.1× 146 1.2k
Peer Hantschmann Germany 15 132 0.3× 399 0.9× 249 1.1× 178 0.9× 113 0.7× 36 837
Shannon Salvador Canada 18 621 1.2× 580 1.3× 143 0.6× 207 1.0× 93 0.6× 74 959
Fatih Güçer Türkiye 16 340 0.7× 337 0.8× 148 0.6× 80 0.4× 170 1.1× 46 737
Rodrique Mortel United States 12 533 1.1× 500 1.1× 187 0.8× 427 2.1× 81 0.5× 17 1.0k

Countries citing papers authored by Derek Cruickshank

Since Specialization
Citations

This map shows the geographic impact of Derek Cruickshank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Cruickshank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Cruickshank more than expected).

Fields of papers citing papers by Derek Cruickshank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Cruickshank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Cruickshank. The network helps show where Derek Cruickshank may publish in the future.

Co-authorship network of co-authors of Derek Cruickshank

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Cruickshank. A scholar is included among the top collaborators of Derek Cruickshank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Cruickshank. Derek Cruickshank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kew, Fiona & Derek Cruickshank. (2006). Routine follow-up after treatment for a gynecological cancer: a survey of practice. International Journal of Gynecological Cancer. 16(1). 380–384. 41 indexed citations
2.
Nevin, James, et al.. (2005). Metastatic adenocarcinoma of right supraclavicular fossa – delayed presentation of ovarian primary. Journal of Obstetrics and Gynaecology. 25(5). 528–529. 7 indexed citations
3.
Mäenpää, Johanna, Derek Cruickshank, Jonathan A. Ledermann, et al.. (2005). SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer. British Journal of Cancer. 94(1). 55–61. 8 indexed citations
4.
Kew, Fiona, Anthony Roberts, & Derek Cruickshank. (2005). The role of routine follow-up after gynecological malignancy. International Journal of Gynecological Cancer. 15(3). 413–419. 53 indexed citations
5.
Kew, Fiona, Vicki Whittaker, & Derek Cruickshank. (2004). Preconceptions versus experience of transvaginal ultrasonography in older women. Ultrasound in Obstetrics and Gynecology. 24(5). 572–574. 3 indexed citations
6.
Tjalma, Wiebren, Peter A. van Dam, Amin Makar, & Derek Cruickshank. (2004). The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients. International Journal of Gynecological Cancer. 14(5). 931–937. 61 indexed citations
7.
Paul, James, et al.. (2002). Does the Interval from Primary Surgery to Chemotherapy Influence Progression-Free Survival in Ovarian Cancer?. Gynecologic Oncology. 86(3). 354–357. 41 indexed citations
8.
Lincoln, Karen D., et al.. (1999). Medical termination of pregnancy at 63 to 83 days gestation. BJOG An International Journal of Obstetrics & Gynaecology. 106(6). 535–539. 46 indexed citations
9.
Kaye, S.B., James Paul, J Cassidy, et al.. (1996). Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.. Journal of Clinical Oncology. 14(7). 2113–2119. 103 indexed citations
10.
Cruickshank, Derek, et al.. (1993). Caesarean section audit by peer review. European Journal of Obstetrics & Gynecology and Reproductive Biology. 48(1). 9–14. 11 indexed citations
11.
Milner, B J, Lindsey Allan, Derek Cruickshank, et al.. (1993). Linkage studies with 17q and 18q markers in a breast/ovarian cancer family.. PubMed. 52(4). 761–6. 8 indexed citations
12.
Booth, N. A., et al.. (1993). Plasminogen activator inhibitors (PAI‐1 and PAI‐2) in normal pregnancies, pre‐eclampsia and hydatidiform mole. BJOG An International Journal of Obstetrics & Gynaecology. 100(4). 370–374. 62 indexed citations
13.
Cruickshank, Derek, N E Haites, Stewart Anderson, et al.. (1992). The multidisciplinary management of a family with epithelial ovarian cancer. BJOG An International Journal of Obstetrics & Gynaecology. 99(3). 226–231. 8 indexed citations
14.
Cruickshank, Derek, et al.. (1992). Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 45(1). 47–51. 33 indexed citations
15.
Cruickshank, Derek, et al.. (1992). CA125‐response assessment in epithelial ovarian cancer. International Journal of Cancer. 51(1). 58–61. 12 indexed citations
16.
Kaye, Stan B., Craig Lewis, James Paul, et al.. (1992). Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer. The Lancet. 340(8815). 329–333. 126 indexed citations
17.
Cruickshank, Derek, et al.. (1992). Intra-uterine growth retardation and maternal labetatol treatment in a random allocation controlled study. Journal of Obstetrics and Gynaecology. 12(4). 223–227. 14 indexed citations
18.
Cruickshank, Derek. (1990). Aetiological importance of ovulation in epithelial ovarian cancer: a population based study.. BMJ. 301(6751). 524–525. 17 indexed citations
19.
Cruickshank, Derek, et al.. (1988). The clinical significance of pre‐operative serum CA 125 in ovarian cancer. International Journal of Gynecology & Obstetrics. 26(3). 476–476. 3 indexed citations
20.
Ward, B., Derek Cruickshank, D. F. Tucker, & Sharon Love. (1988). Independent expression in serum of three tumor‐associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma. International Journal of Gynecology & Obstetrics. 26(3). 475–475. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramey D. Littell Breakdown of academic impact, for papers by Elisabeth Diver Breakdown of academic impact, for papers by Mario Beiner Breakdown of academic impact, for papers by Emanuela Rabaiotti Breakdown of academic impact, for papers by Jason Dodge Breakdown of academic impact, for papers by Taner Turan Breakdown of academic impact, for papers by Peer Hantschmann Breakdown of academic impact, for papers by Shannon Salvador Breakdown of academic impact, for papers by Fatih Güçer Breakdown of academic impact, for papers by Rodrique Mortel
Rankless by CCL
2026